606 related articles for article (PubMed ID: 7870068)
21. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
22. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
23. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
[TBL] [Abstract][Full Text] [Related]
24. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation.
Schmidt CA; Oettle H; Peng R; Neuhaus P; Blumhardt G; Lohmann R; Wilborn F; Osthoff K; Oertel J; Timm H
Transplantation; 1995 Apr; 59(8):1133-8. PubMed ID: 7732559
[TBL] [Abstract][Full Text] [Related]
25. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
26. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
Zhang C; Shen K; Jiang Z; He X
Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
[TBL] [Abstract][Full Text] [Related]
27. A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation.
Gentile G; Picardi A; Capobianchi A; Spagnoli A; Cudillo L; Dentamaro T; Tendas A; Cupelli L; Ciotti M; Volpi A; Amadori S; Martino P; de Fabritiis P
BMC Infect Dis; 2006 Nov; 6():167. PubMed ID: 17118205
[TBL] [Abstract][Full Text] [Related]
28. Relation between pp65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients.
Solà R; Rabella N; Guirado LL; Díaz JM; Facundo C; García R
Transplant Proc; 2005 Nov; 37(9):3768-9. PubMed ID: 16386533
[TBL] [Abstract][Full Text] [Related]
29. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
[TBL] [Abstract][Full Text] [Related]
30. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
31. CMV PCR in leucocytes as an early marker for the development of CMV disease in AIDS patients.
Quarner H; Grützmeier S; Lewensohn-Fuchs I; Hejdeman B; Sandström E; Ehrnst A
Scand J Infect Dis Suppl; 1995; 99():94-5. PubMed ID: 8668950
[TBL] [Abstract][Full Text] [Related]
32. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
[TBL] [Abstract][Full Text] [Related]
33. [Early diagnosis of cytomegalovirus infection and disease in patients following kidney transplantation].
Cathomas G; Tamm M; Bock A; Gudat F; Thiel G; Reusser P
Schweiz Med Wochenschr; 1994 Nov; 124(45):2042-5. PubMed ID: 7973539
[TBL] [Abstract][Full Text] [Related]
34. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
35. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
[TBL] [Abstract][Full Text] [Related]
36. Virological diagnosis of cytomegalovirus in renal transplantation: comparison of three diagnostic methods: DNA in plasma by PCR, PP65 leukocytic antigenemia, and viremia.
Eckart P; Brouard J; Legoff C; Freymuth F; Duhamel JF; Ryckelynck JP; Hurault De Ligny B
Transplant Proc; 1996 Oct; 28(5):2806-7. PubMed ID: 8908069
[No Abstract] [Full Text] [Related]
37. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
38. Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole blood.
Thorne LB; Civalier C; Booker J; Fan H; Gulley ML
Diagn Mol Pathol; 2007 Jun; 16(2):73-80. PubMed ID: 17525675
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two commercially available pp65 antigenemia tests and COBAS Amplicor CMV Monitor for early detection and quantification of episodes of human CMV-viremia in transplant recipients.
May G; Kuhn JE; Eing BR
Intervirology; 2006; 49(5):261-5. PubMed ID: 16714854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
